We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Astellas Gene Therapies Halts Trial After Fourth Patient Death
Astellas Gene Therapies Halts Trial After Fourth Patient Death
A fourth boy has died in Astellas Gene Therapies’ 24-patient ASPIRO study of AT132, an adeno-associated virus vector treatment for myotubular myopathy.